PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC

Clinical trial NCT06742424 · RECRUITING

Trial details

NCT number: NCT06742424
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2024-10-01
Primary completion: 2027-04-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.